Skip to main content

11 Dead in ‘Safe and Effective’ Bird Flu Vaccine Trial as Big Pharma Races to Roll Out Jabs

Serious safety issues have arisen after 11 people died during trials for the bird flu vaccine AUDENZ™, which was promoted as “safe and effective” by the FDA. These deaths, reportedly covered up by mainstream media, have raised doubts about whether lessons from the contentious COVID-19 vaccine rollout are being learned. With increasing alarm regarding a potential bird flu pandemic, pharmaceutical companies and health authorities are fast-tracking H5N1 vaccine development, which has sparked further safety concerns.

Dr. Leana Wen, a public health advocate, has urged the Biden administration to speed up vaccine authorization to strengthen national defenses. She emphasized that delays could leave the country unprepared for serious risks. Critics, however, argue that the hurried development of AUDENZ™ reflects the same errors made during the COVID-19 vaccine launch, where lack of transparency in safety testing led to a loss of public trust and an increase in adverse events.

The UK has ordered five million doses of the AUDENZ™ vaccine as part of their pandemic readiness strategy, with other countries expected to follow. However, the trial’s results are concerning, as, besides the 11 deaths, participants also showed increased troponin T levels, indicating possible heart damage. Moreover, the trial's limited monitoring period of just a few weeks raises questions about the long-term safety and effectiveness of the vaccine.

Dr. Richard Bartlett criticized the short observation period, stating it is insufficient for assessing long-term effects. He also highlighted that AUDENZ™ only provides protection against the specific H5N1 subtype, raising issues if the virus mutates. Dr. Bartlett insisted that the public deserves comprehensive information before significant vaccine distribution begins.

The current push for bird flu vaccines has brought back memories of the rapid COVID-19 vaccine rollout, which many believe prioritized speed over safety. Adverse events reported during that period, including myocarditis and blood clots, have fueled skepticism towards health authorities. Dr. Bartlett remarked that the mistakes from the COVID-19 vaccine rollout should have taught that rushing safety protocols leads to severe consequences.

While pandemic preparedness is vital, it cannot compromise rigorous safety measures or ethical practices. Critics argue that elite global players and pharmaceutical companies exploit public fear, fueled by continuous media alarmism, to forward their agendas, coercing the public to accept hastily developed vaccines with little transparency.

Dr. Wen's urgent call to action coincides with increasing pressure on the Biden administration from pharmaceutical companies. However, a change in administration could impact vaccine policies, especially with the expected scrutinization under a potential Trump administration and figures like Robert F. Kennedy Jr. being placed in significant health roles. 

https://thepeoplesvoice.tv/11-dead-in-safe-and-effective-bird-flu-vaccine-trial-as-big-pharma-races-to-roll-out-jabs/

Comments

Popular posts from this blog

Fauci Files Reveal Pfizer Helped Biden Rig 2020 Election

 Pfizer secretly colluded with Joe Biden's team to help him rig the 2020 election against Trump, according to new Fauci documents. In his new book, "On Call," Fauci admits that Albert Bourla, the CEO of Pfizer, called him the night after Biden was declared the winner of the election, to inform him of Pfizer's "Game-changing results" from the rigged mRNA trial. "On November 7, after the absentee ballots were counted, Joe Biden was declared the winner of the presidential election. It was the very next night that Albert Bourla, Pfizer's CEO, called me away from my neighbors' fire pit to inform me about the game-changing results from the Pfizer mRNA vaccine trial. I finally thought we had truly turned a corner in defeating this terrible disease." Today reports: In another interesting tidbit, Fauci discusses Trump's FDA Commissioner Stephen Hahn declaring that he would not go along with the Trump Administration's plan to roll out the vac...

Republicans Withdraw $1 Billion From BlackRock Due To Its ESG Policies

  Multiple U.S. states governed by Republicans are withdrawing state funds from BlackRock's management, as they disapprove of the ESG investment policies of the world's top asset manager, the Financial Times reports. In recent weeks, Louisiana, South Carolina, Utah, and Arkansas have announced they would divest funds from... For months now, Republican states have said they would not do business anymore with asset managers who have ESG-aligned investment policies, which, the states say, show that those financial firms are boycotting the oil and gas industry. Texas is leading the campaign against this movement The Lone Star State published a list of financial firms that could be banned from doing business with Texas, its state pension funds, and local governments. https://oilprice.com/Latest-Energy-News/World-News/Republicans-Withdraw-1-Billion-From-BlackRock-Due-To-Its-ESG-Policies.html

EU Ambassador & Munich Security Conference Chair Headline Chinese Communist Party Influence Event.

  The Vice Chairman of the Munich Security Conference and a former Ambassador of the European Union to the U.S. headlined an event sponsored by a leading Chinese Communist Party influence group The China-United States Exchange Foundation (CUSEF) CUSEF has been identified by the US government as part of China’s “United Front” which works “to co-opt and neutralize sources of potential opposition to the policies and authority of its ruling Communist Party.” O’Sullivan Director General of the Institute of International and European Affairs Has held a variety of influential positions within the European Union including Chief Operating Officer of the European External Action Service (EEAS) Ruge also has ties to the EU’s military infrastructure Vice Chairman of the Munich Security Conference https://thenationalpulse.com/2022/10/20/eu-amb-and-munich-chair-headline-cusef-webinar/